Related Experiment Video
Updated: Jun 1, 2026

09:28
Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells
Published on: February 2, 2013
Simple and efficient chemosensitivity assay for human primary tumor-cells using contact-sensitive microtiter plates
K Mitsugi1, S Nakano, M Nakayama
1KYUSHU UNIV,FAC MED,DEPT INTERNAL MED 1,3-1-1 MAIDASHI,FUKUOKA 812,JAPAN.
International Journal of Oncology
|May 18, 2011
Summary
A new chemosensitivity assay using cell mats efficiently tests human primary tumors against multiple anticancer drugs. This rapid method provides dose-response curves within five days, aiding personalized cancer treatment strategies.
Area of Science:
- Oncology
- Cell Biology
- Drug Discovery
Background:
- Accurate chemosensitivity testing is crucial for effective human primary tumor treatment.
- Existing assays can be time-consuming and require significant sample material.
Purpose of the Study:
- To develop a simple, efficient, and rapid chemosensitivity assay for human primary tumors.
- To evaluate the feasibility of using a 96-well microtiter plate system with cell mats for drug sensitivity testing.
Main Methods:
- Human primary tumor cells were cultured on lethally irradiated 3T3 cell monolayers (cell mats) in 96-well plates.
- Cells were treated with various anticancer drugs (adriamycin, mitomycin C, cisplatin, etoposide, 5-fluorouracil) at different concentrations.
- Cell proliferation was assessed by H-3-deoxyuridine incorporation and measured using a scintillation counter.
Main Results:
- Complete dose-response curves were obtained for multiple drugs from a single plate within 5 days.
- The assay successfully generated cell survival curves from 30 out of 35 (77%) evaluable primary tumor specimens.
- A high evaluable rate was observed, potentially due to the feeder effect of the cell mats.
Conclusions:
- The developed cell mat-based assay is a simple, efficient, and rapid method for human primary tumor chemosensitivity testing.
- The system's ability to test multiple drugs simultaneously on a single plate offers advantages for personalized cancer therapy.
- Further optimization is needed, but the assay shows significant promise for clinical application.

